Weihong Yang Selected Research

Weihong Yang Research Topics

Disease

11	Neoplasms (Cancer) 07/2023 - 06/2015
8	Ovarian Neoplasms (Ovarian Cancer) 01/2020 - 06/2015
3	Myoma 04/2022 - 05/2008
3	Adenomyosis 10/2021 - 01/2017
3	Leiomyoma (Uterine Fibroids) 01/2015 - 03/2014
3	Hypoxia (Hypoxemia) 05/2014 - 04/2012
2	Pain (Aches) 09/2023 - 10/2021
2	Inflammation (Inflammations) 01/2022 - 12/2019
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 04/2021 - 10/2020
2	Chromosome Aberrations (Chromosome Abnormalities) 12/2019 - 08/2016
1	Type 2 Diabetes Mellitus (MODY) 10/2023
1	Diabetic Nephropathies (Diabetic Nephropathy) 10/2023
1	Peripheral Nervous System Diseases (PNS Diseases) 10/2023
1	Kidney Calculi (Kidney Stone) 09/2023
1	Hepatocellular Carcinoma (Hepatoma) 01/2022
1	Lung Injury 01/2022
1	Infections 01/2022
1	Adenocarcinoma 01/2022
1	Liver Neoplasms (Liver Cancer) 01/2022
1	Pneumonia (Pneumonitis) 01/2022
1	Hemorrhage 10/2021
1	Shock 10/2021
1	Dysmenorrhea (Menstrual Pain) 10/2021
1	Rabies (Hydrophobia) 11/2020
1	Leukemia 12/2019
1	Menorrhagia 12/2018
1	Ovarian Epithelial Carcinoma 09/2018
1	Neoplasm Metastasis (Metastasis) 09/2018
1	Ovarian Cysts (Ovarian Cyst) 09/2018
1	Death (Near-Death Experience) 06/2018
1	Colorectal Neoplasms (Colorectal Cancer) 04/2018
1	Temporal Lobe Epilepsy 04/2017
1	Carcinogenesis 09/2015
1	IgA Vasculitis (Purpura, Schoenlein Henoch) 01/2015
1	Brain Hypoxia-Ischemia (Hypoxia Ischemia, Brain) 10/2014
1	Cardiac Arrhythmias (Arrythmia) 05/2014
1	Heart Injuries 05/2014
1	Endometriosis 03/2014

Drug/Important Bio-Agent (IBA)

9	Messenger RNA (mRNA)IBA 12/2018 - 07/2011
7	Proteins (Proteins, Gene)FDA Link 01/2022 - 07/2011
2	Interleukin-8 (Interleukin 8)IBA 01/2020 - 01/2017
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/2018 - 10/2014
2	HMGB1 Protein (HMG1)IBA 09/2018 - 04/2017
2	Interleukin-6 (Interleukin 6)IBA 01/2017 - 10/2014
2	RNA (Ribonucleic Acid)IBA 08/2015 - 06/2015
2	Oxygen (Dioxygen)IBA 05/2014 - 04/2012
1	Indicators and Reagents (Reagents)IBA 10/2023
1	NAD (NADH)IBA 10/2023
1	Uric Acid (Urate)IBA 09/2023
1	AntigensIBA 01/2022
1	alpha-Fetoproteins (alpha-Fetoprotein)IBA 01/2022
1	Complement System Proteins (Complement)IBA 01/2022
1	olaparibIBA 01/2022
1	Coronavirus Nucleocapsid ProteinsIBA 01/2022
1	Mannose-Binding Protein-Associated Serine Proteases (Mannose-Binding Protein-Associated Serine Protease)IBA 01/2022
1	RibonucleoproteinsIBA 01/2022
1	Hemoglobins (Hemoglobin)IBA 10/2021
1	Guanosine Diphosphate (GDP)IBA 11/2020
1	BoranesIBA 10/2020
1	UbiquitinIBA 01/2020
1	Hydroxyurea (Hydrea)FDA LinkGeneric 12/2019
1	Protein Kinases (Protein Kinase)IBA 12/2018
1	rho GTPase-activating proteinIBA 12/2018
1	MetalsIBA 06/2018
1	NF-kappa B (NF-kB)IBA 01/2018
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2017
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 10/2016
1	Metalloproteases (Metalloproteinases)IBA 10/2016
1	Matrix Metalloproteinases (MMPs)IBA 10/2016
1	Proto-Oncogene Proteins c-etsIBA 01/2016
1	Long Noncoding RNAIBA 09/2015
1	Adrenocorticotropic Hormone (ACTH)FDA Link 01/2015
1	LipopolysaccharidesIBA 01/2015
1	C-Reactive ProteinIBA 10/2014
1	Therapeutic UsesIBA 05/2014
1	Apoptosis Regulatory ProteinsIBA 05/2014
1	ArsenicIBA 05/2014
1	Drinking WaterIBA 05/2014
1	Estrogen Receptor betaIBA 05/2014
1	Ryanodine Receptor Calcium Release Channel (Ryanodine Receptor)IBA 03/2014
1	CalciumIBA 03/2014
1	GonadotropinsIBA 03/2014
1	Heparin (Liquaemin)FDA LinkGeneric 03/2014
1	Inositol (Myoinositol)IBA 03/2014

Therapy/Procedure

8	Therapeutics 01/2022 - 05/2014
3	Minimally Invasive Surgical Procedures 07/2023 - 01/2018
3	Uterine Myomectomy 04/2022 - 05/2008
3	Hysterectomy 10/2021 - 01/2018
1	Radiofrequency Ablation 01/2022
1	Investigational Therapies (Experimental Therapy) 01/2022
1	Nerve Block (Nerve Blocks) 10/2021
1	Electrocoagulation (Electrocautery) 10/2021
1	Catheters 10/2021
1	Uterine Artery Embolization 10/2021
1	Length of Stay 04/2021
1	Laparotomy 04/2021
1	Immunomodulation 12/2019
1	Chinese Traditional Medicine (Traditional Chinese Medicine) 04/2018
1	Perioperative Period 04/2018
1	Aftercare (After-Treatment) 01/2015